Stock Market News

Catalyst Biosciences stock initiated with Buy rating at Stifel on cancer drug

Jun 24, 2025 - 22:06
 0
Catalyst Biosciences stock initiated with Buy rating at Stifel on cancer drug
Read More

Tags:

Previous Article

Goldman Sachs announces firmwide launch of AI assistant

Next Article

Louisiana Attorney General Liz Murrill sues CVS for unlawful practices

Related Posts

Perplexity, PayPal partner to provide easy payment checkouts to users

Perplexity, PayPal partner to provide easy payment chec...

May 14, 2025  0

ProFrac rating downgraded by S&P Global due to liquidity concerns

ProFrac rating downgraded by S&P Global due to liquidit...

May 21, 2025  0

Lithium miner SQM cuts 5% of Chile workforce as prices fail to bounce back

Lithium miner SQM cuts 5% of Chile workforce as prices ...

Jun 25, 2025  0